Rhabdomyosarcoma of the biliary tree: the case for aggressive surgery

Area of Science:

• Pediatric Oncology
• Surgical Oncology
• Medical Research

Background:

• Embryonal rhabdomyosarcoma of the bile ducts presents a significant challenge due to its typical presentation with advanced disease and limited surgical resectability.
• Complete resection is rarely achievable, contributing to a generally poor prognosis for affected children.

Observation:

• This study reports on the management of three pediatric patients diagnosed with embryonal rhabdomyosarcoma originating in the bile ducts.
• Patients presented with jaundice, cachexia, and abdominal masses, with tumors extending into both liver lobes, indicating extensive disease at diagnosis.

Findings:

• Two out of three patients achieved long-term survival, remaining jaundice-free with no evidence of disease at 9 months and 14 years post-treatment.
• The third patient, a long-term survivor, experienced local recurrence after chemotherapy cessation, ultimately expiring 33 months after diagnosis.

Implications:

• Traditional criteria for hepatic tumor resectability may not be applicable to botryoid rhabdomyosarcoma of the bile ducts.
• Aggressive surgical approaches, coupled with modern adjuvant therapies like chemotherapy and irradiation, offer improved survival chances for this rare pediatric malignancy.